Prostate Health Index (phi)

Description

An FDA approved, CE-marked blood test analysis to be used as an aid in distinguishing prostate cancer from benign prostatic conditions1 phi is a proprietary calculation developed by Beckman Coulter Inc. that uses a combination of three blood tests to produce a phi score. This phi score provides more information about what elevated PSA levels might mean and the probability of finding prostate cancer on biopsy.